EDIT vs MCO · rev $32.3M vs P/E 33, rev $7.72B
Editas Medicine Inc (EDIT) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MCO revenue for 2025-12-31 was $7.72B. Net income was $2.46B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
EDIT currently screens at market cap $375.2M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the EDIT and MCO stock pages for the full models.
Not investment advice.